Embolic Protection Devices Market Size, Sjhare, Report by 2033

The global embolic protection devices market size was estimated at USD 1.56 billion in 2023 and is projected to be worth around USD 3.58 billion by 2033, growing at a CAGR of 8.64% from 2024 to 2033.

Key Points

• The North America embolic protection devices market size accounted for USD 560 million in 2023 and is expected to attain around USD 1,310 million by 2033, poised to grow at a CAGR of 8.87% between 2024 and 2033.
• North America has held a major revenue share of 36% in 2023.
• Asia Pacific is expected to show rapid growth in the global market during the forecast period.
• By product, the distal occlusion systems segment held a significant share of the market in 2023.
• By product, the proximal occlusion systems segment is expected to grow rapidly in the market over the projected period.
• By application, the cardiovascular diseases segment has contributed more than 41% of revenue share in 2023.
• By application, the peripheral vascular diseases segment is expected to witness the fastest growth in the market over the forecast period.

The Embolic Protection Devices (EPD) market is an integral segment of the medical devices industry, focusing on devices designed to capture and remove debris that may be released during cardiovascular procedures, particularly in carotid artery stenting and other interventional procedures. These devices aim to reduce the risk of embolization, which can lead to complications such as stroke. The market includes various types of devices, such as distal filter devices, proximal occlusion devices, and distal occlusion devices, each with specific applications and benefits.

Get a Sample: https://www.precedenceresearch.com/sample/4403

Growth Factors

The growth of the Embolic Protection Devices market is primarily driven by the increasing prevalence of cardiovascular diseases, an aging population, and the rising number of minimally invasive surgical procedures. Technological advancements in medical devices, along with improved healthcare infrastructure in emerging economies, are also significant contributors to market expansion. Additionally, increased awareness about the benefits of embolic protection during interventional procedures is fueling market growth.

Region Insights

Regionally, North America holds a dominant position in the Embolic Protection Devices market, largely due to the high incidence of cardiovascular diseases, advanced healthcare systems, and strong presence of major market players. Europe follows closely, driven by a similar prevalence of heart-related conditions and robust healthcare policies. The Asia-Pacific region is expected to witness the fastest growth, attributed to the increasing healthcare expenditure, rising awareness about advanced medical treatments, and a growing geriatric population.

Embolic Protection Devices Market Scope

Embolic Protection Devices Market Dynamics

Drivers

The primary drivers of the Embolic Protection Devices market include the rising incidence of cardiovascular diseases and the growing preference for minimally invasive surgeries, which are less risky and have quicker recovery times. The development of advanced EPD technologies and the increasing adoption of these devices by healthcare professionals are also significant drivers. Furthermore, supportive government initiatives and funding for cardiovascular research and treatments enhance market growth.

Opportunities

The Embolic Protection Devices market presents numerous opportunities, particularly in developing regions where healthcare infrastructure is improving rapidly. The growing trend towards personalized medicine and patient-specific treatments offers potential for customized embolic protection solutions. Additionally, collaborations and partnerships between medical device manufacturers and healthcare providers can lead to innovative product developments and expanded market reach.

Challenges

Despite the promising growth, the Embolic Protection Devices market faces several challenges. High costs associated with advanced EPDs and stringent regulatory requirements can hinder market entry and expansion. The complexity of interventional procedures and the need for specialized training for healthcare professionals also pose significant challenges. Moreover, limited awareness and accessibility in low-income regions may restrict market growth.

Read Also: Self-adhesive Labels Market Size to Reach USD 87.20 Bn by 2033

Embolic Protection Devices Market Recent Developments

• In January 2023, Cardinal Health Inc., a distinguished leader in healthcare services and medical products, embarked on a strategic collaboration with Palantir, a renowned technology company specializing in data integration and analysis. This innovative partnership marks a significant step forward in the realm of healthcare supply chain management.
• In February 2023, Medtronic plc announced the launch of its EnVeo™ drug-eluting stent (DES) for the treatment of patients with PAD.
• In March 2023, Terumo Corporation received a CE mark for its Zilver PTX™ DCB for the treatment of patients with PAD.
• In July 2022, Edwards Lifesciences Corporation announced the FDA approval of its Amplatzer™ Vascular Plug II for the treatment of patients with pulmonary arteriovenous malformations (PAVMs).
• In June 2022, Cook Medical announced the FDA approval of its NirMesh™ Vascular Occlusion Device for the treatment of patients with varicose veins.
• In May 2022, Johnson & Johnson Services, Inc. announced the FDA approval of its Embozene™ Microspheres for the treatment of patients with symptomatic cerebral arteriovenous malformations (AVMs).
• In October 2023, German cardiovascular medical device company Protembis secured US Food and Drug Administration (FDA) approval for its PROTEMBO Pivotal IDE Trial. The ProtEmbo System from Protembis is an intra-aortic filter device offering protection for the brain from embolic material released during a transcatheter aortic valve replacement (TAVR) procedure.

Embolic Protection Devices Market Companies

• Abbott Laboratories
• Allium Medical Solutions Ltd.
• Boston Scientific Corporation
• Cardinal Health Inc.
• Contego Medical LLC
• Innovative Cardiovascular Solutions LLC
• Edwards Lifesciences Corporation
• Medtronic Inc.
• Silk Road Medical Inc.

Segments Covered in the Report

By Product

• Distal Occlusion Filters
• Proximal Occlusion Filters
• Distal Filters

By Application

• Neurovascular Diseases
• Cardiovascular Diseases
• Peripheral Vascular Diseases

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts